Instil Bio, Inc. (TIL)
NASDAQ: TIL · Real-Time Price · USD
6.96
-0.26 (-3.60%)
At close: Oct 5, 2026, 4:00 PM EDT
6.95
-0.01 (-0.14%)
After-hours: Oct 5, 2026, 7:30 PM EDT
Instil Bio Market Cap
Instil Bio has a market cap or net worth of $47.2 million as of October 5, 2026. Its market cap has decreased by -61.37% in one year.
Market Cap
47.20M
Enterprise Value
64.94M
1-Year Change
-61.37%
Ranking
Category
Stock Price
$6.96
ChartMarket Cap Chart
Since the IPO on March 19, 2021, Instil Bio's market cap has decreased from $2.52B to $47.20M, a decrease of -98.12%. That is a compound annual growth rate of -51.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 47.13M | -36.82% |
| Dec 31, 2025 | 74.60M | -40.12% |
| Dec 31, 2024 | 124.58M | 151.37% |
| Dec 29, 2023 | 49.56M | -39.38% |
| Dec 30, 2022 | 81.76M | -96.29% |
| Dec 31, 2021 | 2.21B | -12.33% |
| Mar 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImageneBio | 52.22M |
| Edesa Biotech | 52.15M |
| Celularity | 51.92M |
| Apollomics | 51.63M |
| Elicio Therapeutics | 50.46M |
| Annovis Bio | 50.28M |
| Serina Therapeutics | 49.78M |
| Dogwood Therapeutics | 49.63M |